Rivaroxaban 20 MG Oral Tablet
Rivaroxaban 20 MG Oral Tablet is a pharmaceutical drug with 9 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
0
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
4
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Excretion of Rivaroxaban in Human Breast Milk
Single Dose Trial of VMX-C001 in Healthy Subjects with and Without FXa Direct Oral Anticoagulant
Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis
Dabigatran Versus Rivaroxaban in Cerebral Venous Thrombosis
Safety and Efficacy of Rivaroxaban and Apixaban in Comparison to Warfarin in Left Ventricular Clot- Clinical Trial
Clinical Trials (9)
Excretion of Rivaroxaban in Human Breast Milk
Single Dose Trial of VMX-C001 in Healthy Subjects with and Without FXa Direct Oral Anticoagulant
Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis
Dabigatran Versus Rivaroxaban in Cerebral Venous Thrombosis
Safety and Efficacy of Rivaroxaban and Apixaban in Comparison to Warfarin in Left Ventricular Clot- Clinical Trial
Bioequivalence of Xaroban 20mg (Rivaroxaban) Tablet and Xarelto 20mg (Rivaroxaban) Tablet Under Fed Conditions
Cost-effectiveness Analysis Between Two Anticoagulation Strategies for Atrial Fibrillation in the Postoperative Period of Coronary Artery Bypass Graft Surgery
A Study to Compare Pharmacokinetic Parameters and Safety Profiles Between AD-109 and AD-1091
Pharmacokinetics and Bioequivalence of Rivaroxaban Tablet in Healthy Chinese Volunteers
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9